41.57 USD
+0.57 (+1.39%)
42.39 USD
+0.82 (+1.97%)
Taking everything into account, VCYT scores 6 out of 10 in our fundamental rating. VCYT was compared to 528 industry peers in the Biotechnology industry. VCYT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. VCYT is growing strongly while it is still valued neutral. This is a good combination! These ratings would make VCYT suitable for growth investing!
1. Profitability
1.1 Basic Checks
- VCYT had positive earnings in the past year.
- In the past year VCYT had a positive cash flow from operations.
- In the past 5 years VCYT reported 4 times negative net income.
- In multiple years VCYT reported negative operating cash flow during the last 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 2.21%, VCYT belongs to the top of the industry, outperforming 89.20% of the companies in the same industry.
- VCYT's Return On Equity of 2.40% is amongst the best of the industry. VCYT outperforms 90.15% of its industry peers.
- VCYT has a better Return On Invested Capital (2.96%) than 89.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.21% | ||
| ROE | 2.4% | ||
| ROIC | 2.96% |
ROA(3y)-2.65%
ROA(5y)-4.39%
ROE(3y)-2.82%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- VCYT's Profit Margin of 6.10% is amongst the best of the industry. VCYT outperforms 89.96% of its industry peers.
- The Operating Margin of VCYT (9.81%) is better than 91.48% of its industry peers.
- VCYT's Gross Margin of 68.53% is amongst the best of the industry. VCYT outperforms 81.06% of its industry peers.
- In the last couple of years the Gross Margin of VCYT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.81% | ||
| PM (TTM) | 6.1% | ||
| GM | 68.53% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VCYT is destroying value.
- The number of shares outstanding for VCYT has been increased compared to 1 year ago.
- The number of shares outstanding for VCYT has been increased compared to 5 years ago.
- VCYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 18.06 indicates that VCYT is not in any danger for bankruptcy at the moment.
- The Altman-Z score of VCYT (18.06) is better than 87.88% of its industry peers.
- There is no outstanding debt for VCYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 18.06 |
ROIC/WACC0.33
WACC8.88%
2.3 Liquidity
- VCYT has a Current Ratio of 6.24. This indicates that VCYT is financially healthy and has no problem in meeting its short term obligations.
- VCYT has a better Current ratio (6.24) than 64.02% of its industry peers.
- A Quick Ratio of 5.96 indicates that VCYT has no problem at all paying its short term obligations.
- The Quick ratio of VCYT (5.96) is better than 63.45% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.24 | ||
| Quick Ratio | 5.96 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 353.33% over the past year.
- Looking at the last year, VCYT shows a quite strong growth in Revenue. The Revenue has grown by 16.41% in the last year.
- Measured over the past years, VCYT shows a very strong growth in Revenue. The Revenue has been growing by 29.93% on average per year.
EPS 1Y (TTM)353.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
Revenue 1Y (TTM)16.41%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.82%
3.2 Future
- VCYT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 51.21% yearly.
- The Revenue is expected to grow by 11.52% on average over the next years. This is quite good.
EPS Next Y76.8%
EPS Next 2Y87.27%
EPS Next 3Y59.79%
EPS Next 5Y51.21%
Revenue Next Year14.5%
Revenue Next 2Y12.7%
Revenue Next 3Y12.38%
Revenue Next 5Y11.52%
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- VCYT is valuated quite expensively with a Price/Earnings ratio of 109.39.
- Compared to the rest of the industry, the Price/Earnings ratio of VCYT indicates a rather cheap valuation: VCYT is cheaper than 89.58% of the companies listed in the same industry.
- VCYT is valuated expensively when we compare the Price/Earnings ratio to 27.47, which is the current average of the S&P500 Index.
- Based on the Price/Forward Earnings ratio of 39.51, the valuation of VCYT can be described as expensive.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of VCYT indicates a rather cheap valuation: VCYT is cheaper than 91.67% of the companies listed in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 24.26. VCYT is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 109.39 | ||
| Fwd PE | 39.51 |
4.2 Price Multiples
- VCYT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. VCYT is cheaper than 91.67% of the companies in the same industry.
- 93.75% of the companies in the same industry are more expensive than VCYT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 33.45 | ||
| EV/EBITDA | 40.02 |
4.3 Compensation for Growth
- VCYT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- VCYT has a very decent profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as VCYT's earnings are expected to grow with 59.79% in the coming years.
PEG (NY)1.42
PEG (5Y)N/A
EPS Next 2Y87.27%
EPS Next 3Y59.79%
5. Dividend
5.1 Amount
- VCYT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
41.57
+0.57 (+1.39%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)01-11 2026-01-11/amc
Earnings (Next)05-05 2026-05-05/amc
Inst Owners114.83%
Inst Owner Change-0.02%
Ins Owners0.42%
Ins Owner Change-3.94%
Market Cap3.29B
Revenue(TTM)495.14M
Net Income(TTM)30.18M
Analysts82.11
Price Target49.7 (19.56%)
Short Float %6.68%
Short Ratio5.63
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-15.65%
Min EPS beat(2)-110.32%
Max EPS beat(2)79.03%
EPS beat(4)2
Avg EPS beat(4)-1.91%
Min EPS beat(4)-110.32%
Max EPS beat(4)79.03%
EPS beat(8)5
Avg EPS beat(8)108.97%
EPS beat(12)8
Avg EPS beat(12)67.3%
EPS beat(16)12
Avg EPS beat(16)58.01%
Revenue beat(2)2
Avg Revenue beat(2)4.54%
Min Revenue beat(2)3.31%
Max Revenue beat(2)5.76%
Revenue beat(4)3
Avg Revenue beat(4)2.42%
Min Revenue beat(4)-0.39%
Max Revenue beat(4)5.76%
Revenue beat(8)7
Avg Revenue beat(8)4.03%
Revenue beat(12)11
Avg Revenue beat(12)4.6%
Revenue beat(16)15
Avg Revenue beat(16)5.32%
PT rev (1m)0%
PT rev (3m)17.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)14.94%
EPS NY rev (1m)1.3%
EPS NY rev (3m)40.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.48%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)1.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 109.39 | ||
| Fwd PE | 39.51 | ||
| P/S | 6.64 | ||
| P/FCF | 33.45 | ||
| P/OCF | 30.43 | ||
| P/B | 2.61 | ||
| P/tB | 8.24 | ||
| EV/EBITDA | 40.02 |
EPS(TTM)0.38
EY0.91%
EPS(NY)1.05
Fwd EY2.53%
FCF(TTM)1.24
FCFY2.99%
OCF(TTM)1.37
OCFY3.29%
SpS6.26
BVpS15.91
TBVpS5.05
PEG (NY)1.42
PEG (5Y)N/A
Graham Number11.66
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.21% | ||
| ROE | 2.4% | ||
| ROCE | 3.75% | ||
| ROIC | 2.96% | ||
| ROICexc | 4.13% | ||
| ROICexgc | 54.36% | ||
| OM | 9.81% | ||
| PM (TTM) | 6.1% | ||
| GM | 68.53% | ||
| FCFM | 19.84% |
ROA(3y)-2.65%
ROA(5y)-4.39%
ROE(3y)-2.82%
ROE(5y)-4.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.39%
GM growth 5Y-0.79%
F-Score8
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 44.32% | ||
| Cap/Sales | 1.97% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 153.06% | ||
| Profit Quality | 325.55% | ||
| Current Ratio | 6.24 | ||
| Quick Ratio | 5.96 | ||
| Altman-Z | 18.06 |
F-Score8
WACC8.88%
ROIC/WACC0.33
Cap/Depr(3y)39.23%
Cap/Depr(5y)36.18%
Cap/Sales(3y)2.7%
Cap/Sales(5y)2.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)353.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.32%
EPS Next Y76.8%
EPS Next 2Y87.27%
EPS Next 3Y59.79%
EPS Next 5Y51.21%
Revenue 1Y (TTM)16.41%
Revenue growth 3Y26.64%
Revenue growth 5Y29.93%
Sales Q2Q%13.82%
Revenue Next Year14.5%
Revenue Next 2Y12.7%
Revenue Next 3Y12.38%
Revenue Next 5Y11.52%
EBIT growth 1Y433.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year319.96%
EBIT Next 3Y74.15%
EBIT Next 5Y48.27%
FCF growth 1Y237.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y181.1%
OCF growth 3YN/A
OCF growth 5YN/A
VERACYTE INC / VCYT FAQ
What is the fundamental rating for VCYT stock?
ChartMill assigns a fundamental rating of 6 / 10 to VCYT.
What is the valuation status of VERACYTE INC (VCYT) stock?
ChartMill assigns a valuation rating of 6 / 10 to VERACYTE INC (VCYT). This can be considered as Fairly Valued.
How profitable is VERACYTE INC (VCYT) stock?
VERACYTE INC (VCYT) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for VCYT stock?
The Price/Earnings (PE) ratio for VERACYTE INC (VCYT) is 109.39 and the Price/Book (PB) ratio is 2.61.
What is the financial health of VERACYTE INC (VCYT) stock?
The financial health rating of VERACYTE INC (VCYT) is 8 / 10.